Impact of a non-medical switch from tocilizumab to upadacitinib in a cohort of patients with rheumatoid arthritis in routine clinical practice

被引：0
|
作者：
White, Douglas [1 ]
Poppelwell, David [2 ]
机构：
[1] Te Whatu Ora Waikato, Waikato Hosp, Rheumatol Clin, Hamilton, New Zealand
[2] AbbVie Ltd, Med Affairs, Auckland, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2023年 / 136卷 / 1581期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 78
页数：5
相关论文
共 50 条
  • [41] Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice
    Narvaez, Javier
    Magallares, Berta
    Diaz Torne, Cesar
    Victoria Hernandez, Maria
    Reina, Delia
    Corominas, Hector
    Sanmarti, Raimon
    Maria LLobet, Josep
    Rodriguez de la Serna, Arturo
    Miguel Nolla, Joan
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (04) : 386 - 390
  • [42] Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study
    Caporali, R.
    Idolazzi, L.
    Bombardieri, S.
    Ferraccioli, G.
    Gerli, R.
    Govoni, M.
    Cerinic, M. Matucci
    Pomponio, G.
    Salaffi, F.
    Tirri, R.
    Benaglio, F.
    Bianchino, L.
    Sarzi-Puttini, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 919 - 928
  • [43] Characteristics and Outcomes of Rheumatoid Arthritis Patients Treated With Upadacitinib in Real-world Canadian Clinical Practice
    Appleton, Tom
    Patel, Jayesh
    Girard, Tanya
    Bailey, Fiona
    Jones, Hannah
    Durand, Caylib
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 833 - 833
  • [44] DEALING WITH COMORBIDITIES IN RHEUMATOID ARTHRITIS WITH MEDICAL ASSISTANTS. THE PATIENTS' OPINION ON ASSESSMENT AND EDUCATION BY MEDICAL ASSISTANTS DURING ROUTINE CLINICAL PRACTICE
    Kleinert, Stefan
    Rapp, Praxedis
    Ronneberger, Monika
    Wendler, Joerg
    Schuch, Florian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1448 - 1449
  • [45] Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry
    Leffers, Henrik Christian
    Ostergaard, Mikkel
    Glintborg, Bente
    Krogh, Niels Steen
    Foged, Heidi
    Tarp, Ulrik
    Lorenzen, Tove
    Hansen, Annette
    Hansen, Michael Sejer
    Jacobsen, Martin Skov
    Dreyer, Lene
    Hetland, Merete Lund
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) : 1216 - 1222
  • [46] LONG TERM DRUG SURVIVAL FOR BIOSIMILAR SB4 ETANERCEPT IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS PATIENTS WITH A NON-MEDICAL SWITCH FROM ETANERCEPT REFERENCE DRUG
    Haugeberg, Glenn
    Fevang, Bjorg Tilde Svanes
    Bakland, Gunnstein
    Rodevand, Erik
    Diamantopoulos, Andreas
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 710 - 711
  • [47] Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
    Takahashi, Nobunori
    Asai, Shuji
    Kobayakawa, Tomonori
    Kaneko, Atsushi
    Watanabe, Tatsuo
    Kato, Takefumi
    Nishiume, Tsuyoshi
    Ishikawa, Hisato
    Yoshioka, Yutaka
    Kanayama, Yasuhide
    Watanabe, Tsuyoshi
    Hirano, Yuji
    Hanabayashi, Masahiro
    Yabe, Yuichiro
    Yokota, Yutaka
    Suzuki, Mochihito
    Sobue, Yasumori
    Terabe, Kenya
    Ishiguro, Naoki
    Kojima, Toshihisa
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [48] Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
    Nobunori Takahashi
    Shuji Asai
    Tomonori Kobayakawa
    Atsushi Kaneko
    Tatsuo Watanabe
    Takefumi Kato
    Tsuyoshi Nishiume
    Hisato Ishikawa
    Yutaka Yoshioka
    Yasuhide Kanayama
    Tsuyoshi Watanabe
    Yuji Hirano
    Masahiro Hanabayashi
    Yuichiro Yabe
    Yutaka Yokota
    Mochihito Suzuki
    Yasumori Sobue
    Kenya Terabe
    Naoki Ishiguro
    Toshihisa Kojima
    Scientific Reports, 10
  • [49] TREATMENT PERSISTENCE OF BIOLOGICAL THERAPY IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN ROUTINE CLINICAL PRACTICE
    Sousa, S. I.
    Cordeiro, I.
    Ferreira, D.
    Andreozzi, V.
    Felix, J.
    Jorge, A.
    da Silva, J. Canas
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1057 - 1057
  • [50] Impact of Poor Prognostic Factors on Treatment Decisions in Clinical Practice in Patients with Rheumatoid Arthritis: Findings from a US Observational Cohort
    Harrold, L. R.
    Alemao, E.
    Litman, H. J.
    Connolly, S. E.
    Kelly, S.
    Huai, W.
    Rosenblatt, L.
    Rebello, S.
    Kremer, J. M.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345